drugset / Trial / NCT03903718
Evaluation of the Safety and Efficacy of a Monoclonal Antibody to Treat Influenza
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of the study is to evaluate the efficacy and safety of MEDI8852 for the treatment of influenza caused by a wild type A/H1N1 challenge strain in healthy, influenza serosusceptible adults.
Timeline
- Start
- 2020-04-03
- Primary completion
- 2020-10-09
- Completion
- 2020-10-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MEDI8852 | Monoclonal antibody | — | Intravenous |
| Subject | Oseltamivir | Small molecule | 75 mg | Oral |